1 / 15

Disclosures: nothing to disclose

Acellular dermal matrix in tissue expander-based breast reconstruction predicts increased infection and seroma in a multivariate regression model .

kellsie
Télécharger la présentation

Disclosures: nothing to disclose

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acellular dermal matrix in tissue expander-based breast reconstruction predicts increased infection and seroma in a multivariate regression model Eric D Wang BS, Steven T Lanier BA, BS, TayganYilmaz MPH, Brett T Phillips MD, Balvant P Arora MD, Steven M Katz MD, Sami U Khan MD, Alexander B Dagum MD, Duc T Bui, MD Stony Brook University Medical Center Division of Plastic and Reconstructive Surgery American Society of Plastic Surgeons: Plastic Surgery 2010 Toronto, ON

  2. Disclosures: nothing to disclose

  3. Breast reconstruction with tissue expanders • Acellular Dermal Matrix (ADM) is a relatively recent adjuncttoimplant-based breast reconstruction • Suggested benefits include: • Prevention of implant exposure • Improved control of the inframammary fold • Improved aesthetics, with a more natural ptosis • Improved expansion dynamics

  4. Reported complication rates with ADM * Denotes statistical significance ★ No statistical comparison was made

  5. Research question What are the complication risks associated with acellular dermal matrix use?

  6. Methods • Design: retrospective database review • Setting:postmastectomyTE/I breast reconstructions at a single center between 2004 and 2009 • Samplesize • ADM: 105 breasts (77 patients) • non-ADM: 161 breasts (105 patients) • Statistical analysis • Descriptive statistics, Student’s t-, and Fisher’s Exact • Multivariate logistic regression

  7. Model parameters: predictor variables • Age • BMI • Tobacco • Neoadjuvant chemotherapy and radiation • Postop chemotherapy and radiation • ADM use • Indication for mastectomy • Time between stages • JP drain duration • Mastectomy specimen weight • Tissue expander size • Intraoperative fill volume

  8. Modelparameters: outcome variables • Infection • Mastectomy skin necrosis • Seroma • Hematoma • Capsular contracture • Expander explantation due to infection • Reoperation due to complications

  9. Results: baseline patient characteristics * Denotes statistical significance

  10. Results:univariate analysis * Denotes statistical significance

  11. Results: multivariate regression model • Significant independent predictors of infection:

  12. Results: multivariate regression model • Significant independent predictors of seroma formation:

  13. Conclusions • Acellular dermal matrix is associated with increased risk of infection and seroma, independent of other factors influencing operative outcome • Proposed benefits of ADM must be weighed against the risk of increased complications

  14. Minimizing future complications • Understanding the etiology of complications • Refinement of surgical and postoperative care protocols to avoid complications with ADM • Utilizing risk factors to guide patient selection and preoperative planning for breast reconstruction

  15. References and Contact • Preminger BA, McCarthy CM, Hu QY, Mehrara BJ, Disa JJ. The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: a matched-cohort study. Ann PlastSurg60; 510-513; 2008. • Chun YS, Verma K, Rosen H, Lipsitz S, Morris D, Kenney P, Eriksson E. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. PlastReconstrSurg125; 429-436; 2010. • Lanier ST, Wang ED, Chen JJ, Arora BP, Katz SM, Khan SU, Dagum AB, Bui DT. The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann PlastSurg64; 674-678; 2010. • Antony AK, McCarthy CM, Cordeiro PG, Mehrara BJ, Teo EH, Arriaga AF, Disa JJ. Acellular human dermis implantation in 153 immediate two-stage tissue expander breast reconstructions: determining the incidence and significant predictors of complications. PlastReconstrSurg125; 1606-1614; 2010. • Nahabedian MY. AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. PlastReconstrSurg 124: 1743; 2009. • Sbitany H, Sandeen SN, Amalfi AN, Davenport MS, Langstein HN. Acellular dermis-assisted prosthetic breast reconstruction vs complete submuscular coverage: a head-to-head comparison of outcomes. PlastReconstrSurg124: 1735, 2009. Contact: Duc T. Bui, MD Stony Brook University Medical Center Division of Plastic and Reconstructive Surgery HSC T19-060 Stony Brook, NY 11794

More Related